ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 598

The Non-Synonymous Polymorphism IL23R Arg381Gln Is Associated with Ankylosis in Spondyloarthritis

Amir Kadi1, Félicie Costantino2, Brigitte Izac3, Ariane Leboime4, Roula Said-Nahal5, Gilles Chiocchia3 and Maxime A. Breban5, 1Institut Cochin - Université Paris Descartes - INSERM U1016 - CNRS (UMR 8104), Paris, France, 2INSERM U987, Faculté des Sciences de la Santé Simone Veil, Montigny-le-Bretonneux, France, 3Immunology and Hematology Department, Institut Cochin - INSERM U1016 - CNRS (UMR 8104), Paris, France, 4Rheumatology Division, Ambroise-Paré Hospital AP-HP, Boulogne-Billancourt, France, 5Rheumatology Division, Ambroise Paré Hospital (AP-HP), and Versailles Saint Quentin en Yvelines University, Boulogne-Billancourt, France

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), polymorphism and spondylarthropathy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthritis and Psoriatic Arthritis - Pathogenesis, Etiology

Session Type: Abstract Submissions (ACR)

Background/Purpose: Spondyloarthritis (SpA) is a group of articular disorders sharing genetic background. Single-nucleotide polymorphisms (SNP) of the interleukin 23 receptor (IL23R) gene have been reproducibly reported as associated with ankylosing spondylitis (AS) a subset of SpA, defined by advanced radiographic sacroiliitis. Here, we examined the association between several SNPs in the IL23R gene and SpA as a whole. A particular attention was devoted to genotype-phenotype correlations.

Methods:  Eight single-nucleotide polymorphisms (SNPs) located in the IL23R gene were genotyped in a collection of 414 independent French SpA patients and 264 healthy controls. In addition, the most significantly associated polymorphism rs11209026 (Arg381Gln) was genotyped in 156 multiplex families of SpA and in 136 independent trios. Association analyses were carried using UNPHASED, in SpA as a whole group, and then separately in AS and non-radiographic SpA (non-AS) patients.

Results: Strong association with AS was observed in the 3 datasets (case/control, familial and trios) with the non-synonymous polymorphism rs11209026 Arg381Gln (P=2.86 x 10-3 P=4.59 x 10-3 and p=0.02, respectively). In contrast, such association was not detected with the non-AS group (P=0.878, p=0.65 and p=1). Furthermore, association with this polymorphism was significantly different between the AS and non-AS patients in both studies (P=2.5 x 10-3).

Conclusion:  Our results confirm that IL23R polymorphisms are associated with SpA, either in sporadic or in familial cases. However, phenotypic analysis revealed that association with Arg381Gln polymorphism is restricted to the AS subtype, suggesting that IL23R could influence the phenotypic expression of SpA by promoting ankylosis.


Disclosure:

A. Kadi,
None;

F. Costantino,
None;

B. Izac,
None;

A. Leboime,
None;

R. Said-Nahal,
None;

G. Chiocchia,
None;

M. A. Breban,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-non-synonymous-polymorphism-il23r-arg381gln-is-associated-with-ankylosis-in-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology